Charlotte Serra
Charlotte Serra is President of the RAPS Switzerland Chapter and a global quality leader with more than 20 years’ experience across biologics, diagnostics and advanced therapies, including more than 15 years in executive quality leadership and seven years in cell and gene therapy. As VP, Global Head of Quality Operations for Cell Therapy at Galapagos, she led quality oversight for a global decentralised manufacturing network. Her focus is on building scalable quality models that connect regulatory expectations, operational reality and patient needs.
OpinionHow can we ensure consistency in decentralised cell therapy manufacturing?
Following her presentation at Advanced Therapies Europe, Charlotte Serra navigates the complexities of decentralised cell therapy manufacturing.


